🚀 Exciting Partnership Announcement with Eurofins Genomics 🚀
We are thrilled to share that Hurdle has partnered with Eurofins Genomics to revolutionise the development, accessibility, and implementation of complex biomarker technologies. This collaboration promises to drive advancements in fields ranging from drug discovery to healthcare and agriculture.
By leveraging Hurdle's cutting-edge technology platform and Eurofins Genomics' extensive global laboratory network, we are setting new benchmarks for the speed and efficiency of omics testing across various industries. Our partnership is designed to enhance current systems, accelerate innovation, and bring about significant improvements in the application of complex biomarker technologies.
This groundbreaking alliance breaks traditional boundaries, delivering substantial progress in basic research, consumer health, food security, and pharmaceuticals. As one of the first partnerships of its kind, we are proud to be at the forefront of advancing science and implementing complex biomarkers for the benefit of all.
Dr. Tom Stubbs Co-founder of Hurdle, highlights the potential:
"This partnership marks a watershed moment in omics technologies. It accelerates innovation, drastically improves global accessibility, and expands the applications of these technologies. From precision medicine to food security, we are supporting the best researchers in the world to deliver a brighter future for all.”
Stay tuned for more updates as we embark on this exciting journey together! 🌟
#Innovation #Biomarkers #Healthcare #FutureOfScience #EurofinsGenomics
Formulation and Development Scientist at Vytrus Biotech | Pharmacist
2moThank you so much for the warm welcome! I am truly excited to be part of the Vytrus team and really looking forward achieving great things together 🌱🚀